Post-Approval Safety of Cladribine Tablets with Particular Reference to COVID-19 Outcomes: An Update
Multiple Sclerosis Journal
; 28(1_SUPPL):68-69, 2022.
Article
in English
| Web of Science | ID: covidwho-1865940
Search on Google
Collection:
Databases of international organizations
Database:
Web of Science
Language:
English
Journal:
Multiple Sclerosis Journal
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS